Evidence map›Paper›PMID 39451610›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Leveraging Classifier Performance Using Heuristic Optimization for Detecting Cardiovascular Disease from PPG Signals.

Sivamani Palanisamy, Harikumar Rajaguru

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sivamani PalanisamyDepartment of Electronics and Communication Engineering, Jansons Institute of Technology, Coimbatore 641659, India.ORCID 0000-0001-5809-5549
Harikumar RajaguruDepartment of Electronics and Communication Engineering, Bannari Amman Institute of Technology, Sathyamangalam 638401, India.ORCID 0000-0002-2792-0945

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesPhotoplethysmography (PPG) signals, which measure blood volume changes through light absorption, are increasingly used for non-invasive cardiovascular disease (CVD) detection. Analyzing PPG signals can help identify irregular heart patterns and other indicators of CVD.

methodsThis research involves a total of 41 subjects sourced from the CapnoBase database, consisting of 21 normal subjects and 20 CVD cases. In the initial stage, heuristic optimization algorithms, such as ABC-PSO, the Cuckoo Search algorithm (CSA), and the Dragonfly algorithm (DFA), were applied to reduce the dimension of the PPG data. Next, these Dimensionally Reduced (DR) PPG data are then fed into various classifiers such as Linear Regression (LR), Linear Regression with Bayesian Linear Discriminant Classifier (LR-BLDC), K-Nearest Neighbors (KNN), PCA-Firefly, Linear Discriminant Analysis (LDA), Kernel LDA (KLDA), Probabilistic LDA (ProbLDA), SVM-Linear, SVM-Polynomial, and SVM-RBF, to identify CVD. Classifier performance is evaluated using Accuracy, Kappa, MCC, F1 Score, Good Detection Rate (GDR), Error rate, and Jaccard Index (JI).

resultsThe SVM-RBF classifier for ABC PSO dimensionality reduced values outperforms other classifiers, achieving the highest accuracy of 95.12% along with the minimum error rate of 4.88%. In addition to that, it provides an MCC and kappa value of 0.90, a GDR and F1 score of 95%, and a Jaccard Index of 90.48%.

conclusionsThis study demonstrated that heuristic-based optimization and machine learning classification of PPG signals are highly effective for the non-invasive detection of cardiovascular disease.

Indexed as

CVDdimensionality reductionKNNLDALRSVM

Identifiers

PMID39451610
PMCPMC11507182

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.